Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaocui Fang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|September 17, 2021
Synthetic Neutralizing Peptides Inhibit the Host Cell Binding of Spike Protein and Block Infection of SARS-CoV-2Tao Wang, Xiaocui Fang, Tao Wen, et al.
Pharmacological Research|October 14, 2022
Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemiaMeichen Zhang, Yangyang Ge, Shilin Xu, et al.
ACS Applied Materials & Interfaces|August 17, 2022
CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid LeukemiaShilin Xu, Meichen Zhang, Xiaocui Fang, et al.
Chembiochem : a European Journal of Chemical Biology|February 22, 2022
Principles of Amino-Acid-Nucleotide Interactions Revealed by Binding Affinities between Homogeneous Oligopeptides and Single-Stranded DNA MoleculesPengyu Wang, Xiaocui Fang, Rong Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 19, 2013
Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumorsLei Qin, Fayun Zhang, Xiaoyan Lu, et al.
Journal of Hematology & Oncology|November 14, 2021
A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemiaShilin Xu, Meichen Zhang, Xiaocui Fang, et al.
RSC Medicinal Chemistry|August 6, 2025
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress <i>via</i> enhancing T cell responses and sensitizing cells to gemcitabineXin Huang, Hang Wu, Ke Zhu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 2, 2020
Synthetic CXCR4 Antagonistic Peptide Assembling with Nanoscaled Micelles Combat Acute Myeloid LeukemiaJie Meng, Yangyang Ge, Haiyan Xing, et al.
ACS Central Science|January 30, 2019
Principles of Inter-Amino-Acid Recognition Revealed by Binding Energies between Homogeneous OligopeptidesHuiwen Du, Xiaoyu Hu, Hongyang Duan, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|September 17, 2021
Synthetic Neutralizing Peptides Inhibit the Host Cell Binding of Spike Protein and Block Infection of SARS-CoV-2Tao Wang, Xiaocui Fang, Tao Wen, et al.
Pharmacological Research|October 14, 2022
Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemiaMeichen Zhang, Yangyang Ge, Shilin Xu, et al.
ACS Applied Materials & Interfaces|August 17, 2022
CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid LeukemiaShilin Xu, Meichen Zhang, Xiaocui Fang, et al.
Chembiochem : a European Journal of Chemical Biology|February 22, 2022
Principles of Amino-Acid-Nucleotide Interactions Revealed by Binding Affinities between Homogeneous Oligopeptides and Single-Stranded DNA MoleculesPengyu Wang, Xiaocui Fang, Rong Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 19, 2013
Polymeric micelles for enhanced lymphatic drug delivery to treat metastatic tumorsLei Qin, Fayun Zhang, Xiaoyan Lu, et al.
Journal of Hematology & Oncology|November 14, 2021
A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemiaShilin Xu, Meichen Zhang, Xiaocui Fang, et al.
RSC Medicinal Chemistry|August 6, 2025
Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress <i>via</i> enhancing T cell responses and sensitizing cells to gemcitabineXin Huang, Hang Wu, Ke Zhu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 2, 2020
Synthetic CXCR4 Antagonistic Peptide Assembling with Nanoscaled Micelles Combat Acute Myeloid LeukemiaJie Meng, Yangyang Ge, Haiyan Xing, et al.
ACS Central Science|January 30, 2019
Principles of Inter-Amino-Acid Recognition Revealed by Binding Energies between Homogeneous OligopeptidesHuiwen Du, Xiaoyu Hu, Hongyang Duan, et al.
Pageof 4